Medical Oncology

Prof. Dr. Özge Gümüşay

Doctor and researcher Acıbadem Ataşehir Hastanesi İstanbul
Breast NeoplasmsBrain NeoplasmsCarcinoma, Renal CellAdenocarcinomaKidney NeoplasmsLiver NeoplasmsStomach NeoplasmsCOVID-19NeoplasmsOvarian NeoplasmsLaryngeal NeoplasmsCarcinoma, Squamous CellMelanoma
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 13 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Brain Neoplasms 5 publications
  • Carcinoma, Renal Cell 4 publications
  • Adenocarcinoma 3 publications
  • Kidney Neoplasms 3 publications
  • Liver Neoplasms 3 publications
  • Stomach Neoplasms 2 publications
  • COVID-19 2 publications
  • Neoplasms 2 publications
  • Ovarian Neoplasms 2 publications
  • Laryngeal Neoplasms 2 publications
  • Carcinoma, Squamous Cell 2 publications
  • Melanoma 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: acibadem.com.tr.

  • Meme Kanseri
  • Erkeklerde Meme Kanseri

CV

Education and experience

From source

Experience

  • 2022Acıbadem Sağlık Grubuacibadem.com.tr
  • 2021Stanford University Comprehensive Cancer Center, Palo Alto, Californiaacibadem.com.tr
  • 2019 - 2021UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, (Meme Kanseri Onkolojisi)acibadem.com.tr
  • 2014 - 2019Gaziosmanpaşa Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji Uzmanıacibadem.com.tr
  • 2010 - 2014Gazi Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji Yan Dal Araştırma Görevlisiacibadem.com.tr
  • 2006 - 2010Gazi Üniversitesi Tıp Fakültesi, İç Hastalıkları Araştırma Görevlisiacibadem.com.tr

Education

  • 2023Acıbadem Üniversitesi Tıp Fakültesi / Profesör, Digeracibadem.com.tr
  • 2017Gaziosmanpaşa Üniversitesi Tıp Fakültesi/ Doçent, Digeracibadem.com.tr
  • 2014Gazi Üniversitesi Tıp Fakültesi, Tıbbi Onkoloji, Üst Uzmanlıkacibadem.com.tr
  • 2010Gazi Üniversitesi Tıp Fakültesi, İç Hastalıkları, Uzmanlıkacibadem.com.tr
  • 2005Hacettepe Üniversitesi Tıp Fakültesi, Üniversiteacibadem.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologyacibadem.com.trFrom source
  • Department name at the sourceMeme Kliniğiacibadem.com.trFrom source
  • InstitutionAcıbadem Ataşehir Hastanesiacibadem.com.trFrom source
  • Area of workBreast NeoplasmsExtracted from 13 publications · Model version —From source
  • Publications69 publicationsOpenAlexFrom source
  • Last synchronised4 November 2026 20:44https://www.acibadem.com.tr/doktor/ozge-gumusay/acibadem.com.tr

Scientific work

Publications on Breast Neoplasms

69 publications

  1. Beyond CDK4/6 Inhibition: Current Strategies in Hormone Receptor-Positive Metastatic Breast Cancer

    Current Treatment Options in Oncology, 2026

    DOI 10.1007/s11864-026-01391-3 PMID 41999452 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  2. Immune-related adverse events as predictors of pathological complete response in early-stage triple-negative breast cancer treated with pembrolizumab

    Immunotherapy, 2026

    DOI 10.1080/1750743x.2026.2662201 PMID 42011533 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  3. HER2-low expression in patients with hormone receptor positive and HER2 negative advanced breast cancer treated with ribociclib or palbociclib in combination with endocrine therapy

    Turkish Journal of Clinics and Laboratory, 2025

    DOI 10.18663/tjcl.1639022 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  4. Real-World Treatment Efficacy of Ribociclib or Palbociclib Plus Fulvestrant in Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Clinical Breast Cancer, 2025

    DOI 10.1016/j.clbc.2025.03.003 PMID 40190010 2 citations (Europe PMC) Open-access full textSource: OpenAlex

  5. Abstract P4-11-03: Prediciting high risk hormone receptor (HR) positive Her-2 negative early breast cancer (BC) by artificial intelligence (AI) algorithms

    Clinical Cancer Research, 2025

    DOI 10.1158/1557-3265.sabcs24-p4-11-03 Source: OpenAlex

  6. Real-world data on the efficacy and safety of trastuzumab emtansine in patients with metastatic breast cancer previously treated with pertuzumab: Turkish oncology group multicenter study

    Journal of Chemotherapy, 2024

    DOI 10.1080/1120009x.2024.2366683 PMID 38904164 1 citation (Europe PMC) Source: OpenAlex

  7. Adrenocortical Cancer in the Real World: A Comprehensive Analysis of Clinical Features and Management from the Turkish Oncology Group (TOG)

    Clinical Genitourinary Cancer, 2024

    DOI 10.1016/j.clgc.2024.102077 PMID 38626660 2 citations (Europe PMC) Source: OpenAlex

  8. Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study

    BMC Cancer, 2024

    DOI 10.1186/s12885-024-13357-5 PMID 39736618 4 citations (Europe PMC) Open-access full textSource: OpenAlex

  9. Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study

    Journal of Cancer Research and Clinical Oncology, 2023

    DOI 10.1007/s00432-023-04766-3 PMID 37067546 7 citations (Europe PMC) Open-access full textSource: OpenAlex

  10. Systemic therapy for hormone receptor‐positive/human epidermal growth factor receptor 2‐negative early stage and metastatic breast cancer

    CA A Cancer Journal for Clinicians, 2023

    DOI 10.3322/caac.21777 PMID 36939293 182 citations (Europe PMC) Source: OpenAlex

View all 69 publications